A nomogram combining clinical features and CT imaging features before treatment was developed, which can effectively and simply predict the efficacy response of advanced gastric cancer patients treated with PD-1 inhibitors combined with chemotherapy. This evidence concerns the gene PDCD1 and gastric cancer.